Home / One Health /

The One Health approach emphasises the interdependence of human, animal, and environmental health in the context of AMR. Addressing AMR effectively requires a coordinated approach that integrates efforts across all three sectors to mitigate its impact globally.

Investors with US$13.9 trillion in assets signed a statement urging policymakers to act on critical requests to tackle AMR.

Australia could benefit from nano-antimicrobial particles to increase the effective lifespan of current and new antimicrobial medicines, but barriers remain.

CSIRO experts are using artificial intelligence (AI) in the search for new antibiotics and say it will lead to a better hit rate of successful pharmaceutical candidates.

Contrary to a common belief, antibiotic resistance is not about your body becoming resistant to antibiotics.

A comprehensive One Health approach addresses the interconnectedness of human, animal, and environmental health.

AMR occurs when microbes, such as bacteria, viruses, fungi, and parasites evolve to resist the drugs designed to kill them, rendering treatments ineffective.

AI Machine Learning could potentially unblock the antimicrobial drug development pipeline.

Six key ways that Australia can shore up its antimicrobial stewardship, including optimising antimicrobial use and increasing education.

The push and pull ideas helping to bring new antibiotics to market.

Australia is well-positioned in the global effort to combat AMR.